Abstract
The rising rates of substance misuse have resulted in the upsurge of neonatal abstinence syndrome (NAS) worldwide, including India. Neonatal opioid withdrawal syndrome (NOWS) is a subset of NAS resulting from chronic in-utero exposure to opioids. Diagnosing NOWS can be particularly difficult because its symptoms can be vague, and mothers may intentionally withhold information about their drug use. Till now, only a limited number of cases of NOWS have been reported from India. We present a case of NOWS presenting as status epilepticus. There was no history of maternal substance misuse on initial enquiry, and the baby was being managed as a case of idiopathic neonatal seizures. It was only after being informed by the mother’s psychiatrist that she had a history of opioid misuse and was non-compliant with maintenance medications that the probable diagnosis of NOWS could be made. Seizures were managed with phenobarbitone and phenytoin. The baby was discharged on a maintenance dose of phenobarbitone. Due to the rising incidence of substance misuse in our country, a high index of suspicion should be kept for the diagnosis of NAS or NOWS in neonates with unexplained neurological symptoms in the first few days of life.
Keywords
Get full access to this article
View all access options for this article.
